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Abstract
Introduction Approximately 400 000 Americans and
36 000 Canadians undergo cardiac surgery annually,
and up to 56% will develop chronic postsurgical pain
(CPSP). The primary aim of this study is to explore
the association of pain-related beliefs and genderbased pain expectations on the development of CPSP.
Secondary goals are to: (A) explore risk factors for
poor functional status and patient-level cost of illness
from a societal perspective up to 12 months following
cardiac surgery; and (B) determine the impact of CPSP
on quality-adjusted life years (QALYs) borne by cardiac
surgery, in addition to the incremental cost for one
additional QALY gained, among those who develop
CPSP compared with those who do not.
Methods and analyses In this prospective cohort
study, 1250 adults undergoing cardiac surgery,
including coronary artery bypass grafting and openheart procedures, will be recruited over a 3-year period.
Putative risk factors for CPSP will be captured prior to
surgery, at postoperative day 3 (in hospital) and day 30
(at home). Outcome data will be collected via telephone
interview at 6-month and 12-month follow-up. We will
employ generalised estimating equations to model the
primary (CPSP) and secondary outcomes (function and
cost) while adjusting for prespecified model covariates.
QALYs will be estimated by converting data from the
Short Form-12 (version 2) to a utility score.
Ethics and dissemination This protocol has been
approved by the responsible bodies at each of the
hospital sites, and study enrolment began May 2015.
We will disseminate our results through CardiacPain.
Net, a web-based knowledge dissemination platform,
presentation at international conferences and
publications in scientific journals.
Trial registration number NCT01842568.

Strengths and limitations of this study
►► This is a prospective, multisite study with a large

cohort of cardiac surgery patients.
►► One-year follow-up is compliant with Initiative for

Methods, Measurement, and Pain Assessment in
Clinical Trials recommendations to standardise timing of outcome assessment for prognostic studies of
chronic postsurgical pain (CPSP).
►► A robust analysis plan using generalised estimating
equations will be used to model the primary analysis: the association between pain-related beliefs and
gender-based pain expectations with the development of CPSP at 6 months and 1 year while adjusting
for prespecified covariates.
►► Assiduous follow-up procedures will be adhered to,
which have been proven effective in prior prospective observational studies.
►► There is reliance on pain and quality of life self-report outcome measures; however, rigorous criteria
to define CPSP will be applied, and valid and reliable
instruments will be used.

Introduction
Approximately 400 000 Americans and
36 000 Canadians undergo cardiac surgery
annually, and these numbers are expected
to rise as the population ages.1–5 Despite
the proven survival and symptom-related
benefits of cardiac surgeries, mounting
evidence suggests that chronic postsurgical
pain (CPSP)—and related poor functional
recovery—following these procedures are
major clinical problems.6–31 Moreover, the
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CPSP following cardiac surgery
Due to conceptual and methodological differences in
the assessment of pain, and conflicting opinions about
the duration of ‘chronicity’, there is no one accepted
definition of CPSP.32 However, there is consensus among
experts32–38 that CPSP should meet the minimum criteria,
set forth by Macrae and Davies33 and others,34–40 as
follows. It must: (A) have developed after the surgical
procedure, (B) be different from pain experienced prior
to the procedure, (C) not be caused by other factors (eg,
cancer recurrence and chronic infection), (D) be present
for at least 2–3 months and (E) interfere significantly with
health-related quality of life.34–40
Open cardiac surgeries involve many pain-sensitive
structures, as they require a median sternotomy, retraction of the ribs and invasion of muscles and visceral
tissues. In coronary artery bypass surgery (CABG), the
grafting procedure requires harvesting at several sites
including, most commonly, the internal mammary artery
(IMA). The manipulation and retraction of the sternum
as well as the use of electrocautery to dissect the IMA
from the chest wall may result in nerve damage that leads
to intercostal neuralgia.41–44 The greater and lesser saphenous veins are also used as grafts in CABG surgery and
require significant leg incisions. These procedures may
result in pain that can last for variable periods and may be
inflammatory or neuropathic in nature. CPSP in cardiac
surgery patients is often experienced in the thorax and
legs but has also been described, to a lesser degree, in
the shoulders, back and neck.10 12 45 The pathophysiological pathways underlying CPSP are multifactorial. Tissue
damage leads to release of high concentrations of bradykinin, adenosine, lactate and potassium in the peripheral microenvironment, thereby causing nociceptor
activation.46 47 These mediators activate capsaicin-sensitive TRVP1 receptors, which serve as the primary transducer of the noxious stimulus.47 Other neurochemicals,
such as the neuropeptides substance P and calcitonin
gene-related peptide, further augment pain.47 These
peripheral nociceptive processes are modulated in the
central nervous system by mechanisms involving selection, abstraction and synthesis of information from the
total sensory input.48 The amount, quality and nature
of the pain experienced are therefore dynamic and
multidimensional products of sensory-discriminative,
2

cognitive-evaluative and affective-motivational components.48 Like any form of chronic pain, ongoing pain after
surgery can lead to pathological nervous system changes,
collectively known as sensitisation47—a function of what
we now understand to be neuronal modifiability.46 Sensitisation of the nervous system may lead to increased pain
sensitivity (hyperalgesia), augmentation of the normal
duration (hyperpathia) amplitude of pain, perception
of non-painful stimuli as painful (allodynia)47 49 and
abnormal, unpleasant hypersensitivity (dysesthesia).50
As Katz and Seltzer argued,32 critical to understanding
the nature of CPSP is appreciating that in each case, the
pain was once acute and involved a transition phase.
There is much work to be done to continue to develop
our understanding of risk factors, which predispose
cardiac surgical patients to pain chronicity.
Prevalence and consequences
We reviewed 26 published/under review studies to date,
across 14 countries,6–31 which have examined the prevalence and/or factors associated with CPSP following
cardiac surgery. On careful examination of the available
data, it is important to recognise that cross-sectional and
retrospective studies have generally reported higher prevalence rates (14%–56%)%) than those investigations with
prospective designs (7.5%–45%). In the recent (2013)
large-scale Canadian CARDpain study (n=1010), Choinière et al28 reported CPSP prevalence rates of 40%, 22%
and 17% at 3, 6, and 12 months following cardiac surgery,
respectively. Routledge et al31 found similar prevalence
rates of CPSP in their prospective extension (Women’s
Recovery from Sternotomy-Extension (WREST-E)) of a
randomised clinical trial (Women’s Recovery from Sternotomy (WREST)) (n=222) to examine the impact of a
novel compression undergarment on women’s recovery
from median sternotomy (3 months postoperative [postop]: 41%; 12 months post-op: 16.7%). In contrast to
CARDpain and WREST-E, 1 year CPSP prevalence rates as
high as 39% and 45% have been reported in prospective
studies of patients following CABG in Turkey27 and the
Netherlands.30 Aside from differences in study design, the
observed variability in reported prevalence rates of CPSP
after cardiac surgery may be explained by the use of point
prevalence versus cumulative prevalence, variability with
respect to the operational definitions of CPSP, timing of
outcome measurement and duration of follow-up period.
CPSP has been associated with the development of
anxiety and depressive disorders,51–55 sleep disturbances
and fatigue,56–60 as well as poor self-rated health.7 51 53 61
For example, among those with CPSP in the CARDpain
study, over 50% reported significant pain-related interference with activities of daily living—including family and
home responsibilities, recreation and employment—at 3,
6 and 12 months following cardiac surgery.28 62
Risk factors for CPSP
Several studies have attempted to establish risk factors for
CPSP in cardiac surgery patients.
McGillion MH, et al. BMJ Open 2019;9:e022995. doi:10.1136/bmjopen-2018-022995
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economic consequences of persistent pain and dysfunction remain uncertain. Identification of factors associated
with the development of CPSP could facilitate efforts
to improve outcomes among high-risk patients, yet the
majority of putative risk factors examined to date are not
tenably modifiable in the perioperative context. Three
psychological factors that do show promise as modifiable, potential risk factors for CPSP include pain-related
beliefs, gender-based pain expectations and somatic
preoccupation and coping. The purpose of this study is
to examine whether these factors are associated with transition to CPSP following cardiac surgery.
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Demographic factors
Demographic factors examined include age, sex, level
of education, body mass index (BMI) and smoking
history. Younger age has been positively associated with
CPSP7 9 12 17 20 25 28 in multiple retrospective, cross-sectional
and prospective studies, as observational data embedded
within randomised controlled trials (RCTs); significant
ORs have ranged from 1.43 to 7.03 in cases where this
outcome was dichotomised (ie, younger vs older patients).
However, four of the more recent published studies to
date (one retrospective,17one cross-sectional,18 one RCT50
and one prospective21) have found no positive association
between age and the development of CPSP. Conflicting
findings have also been reported for sex. Although some
studies indicate higher risk of CPSP with women,21 29 30
multiple studies with divergent designs9 12 14 18 20 28 48 have
reported no significant association between sex and the
development of CPSP. Examination of BMI as a risk factor
for CPSP has also produced mixed results. While two
studies (one cross-sectional7 and one RCT [embedded
observational data],20 ORs=1.34 and 9.05, respectively)
provided supportive evidence, other cross- sectional17 18
and prospective studies9 28 found no association between
CPSP and BMI (OR range: 1.02–1.1). Finally, we are aware
of two prospective studies to date that have examined the
association of CPSP with formal level of education28 and
smoking history,14 respectively; no significant association
was found in either case.
Baseline clinical, surgical and hospitalisation-related factors
Among baseline clinical factors, neither a history of
diabetes mellitus9 14 17 23 24 50 or peripheral arterial disease24
have been significantly associated with the development
of CPSP.
However, pre-existing peripheral arterial disease has
been examined as a risk factor in just one retrospective
McGillion MH, et al. BMJ Open 2019;9:e022995. doi:10.1136/bmjopen-2018-022995

study24 to date. Similar to diabetes mellitus, the majority of
prospective studies20 21 23 (including one RCT)20 reported
no predictive ability of baseline chronic pain conditions in the literature (OR=1.00–1.04, where reported).
To date, CARDpain28 is the only prospective examination to report that pre-existing chronic pain at baseline
(non-anginal) is positively associated with CPSP (adjusted
OR=1.44, 95% CI 1.12 to 1.86).28
The evidence pertaining to the predictive value of
preoperative angina is also mixed. Two cross-sectional
studies reported preoperative angina that was positively
associated with CPSP (OR, where reported=1.62)7 12;
however, another cross-sectional17 and two additional
large-scale prospective studies14 28 found no significant
associations to infer that preoperative angina is a significant risk factor for CPSP.
The majority of studies have reported no association6 12 13 17 22 28 50 between a range of surgical factors,
including: (A) type of surgical technique, (B) number
and type of bypass grafts per operation, (C) harvesting
technique and (D) total cross-clamp time (ie, total time
aorta is clamped to separate systemic circulation from
cardiac outflow) and the development of CPSP. There
is some evidence to suggest that not skeletonising the
internal thoracic artery harvest (ie, harvesting it along
with its surrounding pedicle of vascular tissue) is more
likely to invoke CPSP64; those who have undergone left
IMA harvesting may also be at higher risk.13 42 In general,
post-op complications and related adverse events (eg,
reoperation for bleeding and infections) have not been
associated with CPSP,9 12 14 16 20 28 with the exception of one
prospective study that identified post-op resternotomy as
a significant risk factor (OR=3.38).21 Cardiac surgeries
of longer duration (ie, total OR time) 18 20 also do not
seem predictive of CPSP; in fact, the CARDpain28 study
found that the longer the OR time, the less likely CPSP
was to develop. Finally, there seems to be no conclusive
evidence to suggest that length of time in the intensive
care unit,18 20 28 or total duration of hospitalisation18
contribute to the development of CPSP after cardiac
surgery.
Acute post-op pain
Two prospective studies found that severe pain (ie,
numeric rating scale [NRS] ≥7/10) on post-op day 3 was a
significant risk factor for CPSP at 1-year follow-up,21 as well
as worst and average pain ratings at 2-year follow-up.28 A
third prospective study found that severe pain on post-op
day 30 positively predicted CPSP at 3 months.23 The association between analgesic therapy and CPSP is uncertain.10–12 18 19 21 23 27 28
Psychological factors
Only the CARDpain28 study has examined the role of
psychological risk factors in the development of CPSP
and found that presurgical anxiety, as measured by the
Hospital Anxiety and Depression Scale (HADS), was a
significant risk factor, with a 10% increase in the odds of
3
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Their limitations can be summarised63 as: (1) many
studies focused on univariate analyses, or were insufficiently powered to employ multivariate modelling techniques, (2) the vast majority of risk factors examined
to date are not tenably modifiable in the perioperative
context, (3) psychological risk factors (affective and
cognitive) are substantially understudied in comparison
with demographic, clinical/surgical and analgesic risk
factors, constituting a major gap and (4) although retrospective and cross-sectional studies provide some insight
on potential variables associated with CPSP, cross-sectional studies lack the temporal orientation to make solid
inferences about putative, causal relationships and retrospective studies can be limited by availability and quality
of data. In addition, even robust retrospective may be
limited in terms of risk factors explored and related data
collection methods. Risk factors for CPSP can be classified into four categories: (A) demographic, (B) baseline
clinical, technical-surgical, and hospitalisation-related
factors, (C) acute post-op pain and (D) psychological
factors.
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Genetic factors
Several members of this investigative team (eg, HC and
JK) are involved in studies investigating the influence
of genetic polymorphisms on the development of CPSP
after cardiac and other types of surgery. The science of
pain genetics is evolving; investigations of this nature are
complex, requiring extensive research infrastructure for
genotyping and related proteomic methods. Controlling
for the influence of genetic factors is beyond the scope
this study.
Conceptual underpinnings and study focus
To address the above noted gap in the research to date, our
primary objective is to examine the potential influence of
psychological factors on the development of CPSP after
cardiac surgery. Clear justification for the specific putative risk factors to be measured requires that we first explicate the conceptual underpinnings of our study. Given
the complexity of the multidimensional pain experience,
there are many ways to conceptualise CPSP.65 We are
aligned with the biobehavioural view of pain, espoused by
international leaders in the science of the cognitive and
learning aspects of pain.65 66 Fundamental to the biobehavioural perspective is the assertion that people learn to
predict future events based on prior learning experiences
and information processing. As such, patients’ behaviours
elicit responses from significant others, including healthcare professionals, which can reinforce both adaptive and
maladaptive modes of thinking, feeling and behaving.65
With this understanding, patients’ pain-related cognitions and behaviours are of chief concern with respect to
identifying factors that may contribute to the transition
from acute post-op pain to chronic pain. In moving the
science forward, we therefore give primacy to the cognitive-behavioural side of the global biobehavioural view of
pain, as the conceptual premise for our primary objective. According to the fundamental tenets of the cognitive-behavioural perspective of pain65 66: (A) behaviour is
reciprocally determined by the person and environment,
(B) people can learn more adaptive ways of thinking and
behaving and (C) people are capable of and should be
involved as active agents in the change of maladaptive
thoughts, amenable to intervention.65 Our focus therefore will be on the contribution of patients’ pain-related
beliefs and expectations, as follows:
Pain-related beliefs
Decades of work9 67–82 in the fields of post-op pain and
anaesthesia has demonstrated that surgical patients have
beliefs about pain and pain medication, which: (A) are
based on incorrect information and (B) serve to block
effective pain assessment and management. For example,
one study found that among patients undergoing CABG
4

surgery (n=202), a majority (83%) reported that they
would not voluntarily ask for pain medication when they
needed it, although most reported unrelieved moderate-to-severe pain from post-op day 2 (80%) until day
5 (69%).67 As of 2013, data indicate that this unfortunate scenario remains largely unchanged. Cogan et al82
found that among cardiac surgery patients (n=564), 36%
believed that ‘pain medication should be spared until the
pain is very severe’, 20% believed that ‘good patients do
not speak of their pain’ and 31% believed it is ‘very easy
to become addicted to pain medication’ while recovering
from surgery. The particular role of these beliefs per se
in the development of CPSP has yet to be examined; we
will do so in this study using the Pain Barriers Questionnaire (PBQ) (validated in multiple populations).
Gender-based pain expectations
As with a number of fields in the health sciences, the
study of sex and gender, as they relate to pain, is evolving.
Our comprehensive review of risk factors for CPSP after
cardiac surgery revealed that, thus far, investigation has
been limited to the contribution of sex only as a risk factor.
For the purposes of this study, we employ the following
distinctions between sex and gender, set forth by Lips,83
which have been adopted in a number of well-cited pain
studies84–99: sex: the biological distinction of being male or
female; gender: learnt masculinity or femininity, related
to socially-constructed roles and behaviours attributed to
men and women in society.83 84
Emerging evidence suggests that gender-based pain
expectations defined as ‘Sex-related stereotypic attributions about pain sensitivity, pain endurance, and willingness to report pain’ 87 may lead to important differences
in the experience of pain and related response. Robinson
et al were among the first to investigate gender-based
pain expectations, using the Gender Role Expectations
of Pain Questionnaire (GREP).87 Their study of pain
cognitions in 156 men and 235 women found that men
were perceived to be less willing to report pain than
women, women were perceived to be more sensitive and
less enduring of pain than men and that men rated their
pain endurance as higher than average. Further testing
of the GREP by Wise et al94 found that after controlling
for age, GREP scores accounted for 7%, 11% and 21%
of the variance in pain threshold, tolerance and pain
unpleasantness scores, respectively, for women (n=87)
and men (n=61) exposed to thermal testing. A recent
meta-analysis by Alabas et al,91 for example, examined
the role of gender-related cognitions in the experience
of pain.91 Pooling the results of six trials (406 men and
539 women), they found that those who considered
themselves more masculine and less sensitive to pain,
than the typical man, exhibited higher pain thresholds
and tolerances in a variety of settings. Using the GREP,
our study will be the first we know of to examine the role
of gender-based pain expectations on the development
of CPSP after cardiac surgery.
McGillion MH, et al. BMJ Open 2019;9:e022995. doi:10.1136/bmjopen-2018-022995
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developing CPSP for each unit increase in HADS-A scale
scores (OR=1.10, 95% CI 1.06 to 1.14). Other psychological risk factors examined (catastrophising and depression) demonstrated no association.
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Cost of illness
We will examine the impact of CPSP on patient-level cost,
calculated from a societal perspective, wherein all costs
irrespective of payer are included thereby comprising
private and public costs, using the Ambulatory Home
Care Record. Data are available that indicate that from
20% to 30% of the occurrence of chronic pain is related to
CPSP.98 99 Given the rates of cardiac surgery in Canada,4 5
literature has shown that CPSP contributes substantially
to the $22.2 billion in direct and indirect costs borne by
cardiovascular interventions and services annually.15 With
a view to comprehensive examination of the impact of
CPSP, we will: (A) estimate the extra cost, expressed in
healthcare costs, for patients with CPSP compared with
those without and (B) estimate an incremental cost-effectiveness ratio, that is, the incremental cost for one
additional quality-adjusted life year (QALY) gained,
by virtue of cardiac surgery, among those who develop
CPSP compared with those who do not. QALY is a preference-based utility measure of health-related quality of
life as perceived by the patient.100 101 QALYs incorporate
both length of life and quality of life into a single measure
and are calculated by combining health- related quality
of life measures with data on health state duration. As
such, QALY is the gold standard measure of effectiveness
recommended for economic evaluation and represents
a universally comparable outcome measure. QALY will
be derived from our Short Form-12 (SF-12) version 2
(SF-12v2) data.
Study objectives
Our primary objective is to examine the influence of
pain-related beliefs and gender-based pain expectations
on the development of chronic pain following cardiac
surgery. Our secondary objectives are to: (A) examine the
influence of pain-related beliefs and gender-based pain
expectations on functional status and patient-level cost of
illness following cardiac surgery; and (B) to determine
the impact of CPSP on the QALY borne by cardiac surgery
and the incremental cost for one additional QALY gained
for patients, by virtue of cardiac surgery, among those
who develop CPSP compared with those who do not.

Methods and analysis
Design
This study is a substudy of the Vascular Events In Surgery
patIents cOhort evaluatioN - Cardiac Surgery study
(https://clinicaltrials.gov/ct2/show/NCT01842568),
examining 30-day all-cause mortality, myocardial injury
and related complications following cardiac surgery
in 15 000 participants. In this substudy, we propose
to prospectively follow a cohort of patients who have
undergone cardiac surgery for 1 year. Data on potential
McGillion MH, et al. BMJ Open 2019;9:e022995. doi:10.1136/bmjopen-2018-022995

predictors will be collected at baseline. The total follow-up
period is 12 months, with pain, functional status and cost
of illness-related data being collected at 6 months and 12
months following cardiac surgery.
Patient and public involvement
We collected patient testimonials to articulate the nature
of the chronic pain problem following cardiac surgery
from the patient perspective and establish the need for
this study. Following the completion of the study, we will
debrief the patient panel with the results of our findings.
Study population
The target population of 1250 cardiac surgery patients
will be recruited from participating hospital sites in
Canada, USA and Hong Kong. Patients eligible for our
study will be undergoing a first-time cardiac surgery
involving a median sternotomy, including CABG and all
open heart procedures, such as valvular repairs/replacement. Eligible patients will also be able to read, speak
and understand English and have a telephone allowing
for follow-up. Patients will be ineligible if they: (A) have
undergone previous cardiac surgery, thoracotomy or
mastectomy, (B) are scheduled for an isolated pericardial
window procedure (due to malignancy), pericardectomy,
permanent pacemaker, or defibrillator implantation, (C)
have a major cognitive disorder precluding participation,
or (D) have a hearing impairment or speech impediment
precluding telephone-based follow-up.
Cardiac surgery inpatients will be recruited in one of
two ways: (1) from the hospital sites preoperative assessment clinic, if their surgery is prebooked, or (2) from
the cardiac surgical ward, if they have been admitted to
hospital via the hospital’s emergency department or the
heart investigation unit. A study nurse will obtain written,
informed consent to participate among those willing and
interested. The study enrolment period will conclude
once the 1-year follow-up telephone interview is complete.
Data collection
Immediately following enrolment, standard baseline
demographic, independent variable data (participants’
age, sex, ethnicity, highest level of formal education,
and marital and employment status) and data on baseline covariates (age and sex) will be collected by the
study nurse via interview and chart audit. Postoperatively, the study nurse will collect data on surgical details
via chart audit, and data on post-op day 3 cumulative
analgesic dose and pain intensity scores via chart audit
and participant interview, respectively. The study nurse
will contact patients by phone at 30 days, and 6 and 12
months after surgery; the 30-day call will be for post-op
pain monitoring, and the two subsequent calls will be for
outcome assessment. Data on dependent variables will be
measured at 6 months and 12 months following cardiac
surgery. Table 1 outlines this visit schedule. The timing
of this follow-up outcome measurement is in compliance
with recommendations (2013) set forth by the Initiative
5
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Health-related quality of life
Overwhelming evidence documents the deleterious
impact of CPSP on health-related quality of life.6–31 50–62
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Baseline
Pain Barriers Questionnaire
Gender-based pain expectations

X
X

Somatic Pre-Occupation and Coping

X

State-Trait Anxiety Inventory

X

Hospital Anxiety and Depression Scale
(HADS)

X

Short Form-12 (SF-12)

X

CPSP-related disability

X

Postoperative day 3 Day 30

X

Analgesic chart audit

X

Brief Pain Inventory
Ambulatory Home Care Record

X

for Methods, Measurement, and Pain Assessment in Clinical Trials to standardise the timing of outcome assessment for prognostic studies of CPSP.102
Dependent variables
Chronic postsurgical pain
The development of CPSP will be measured using a telephone structured interview protocol, defined as pain:
(A) that developed after the surgical procedure, (B) is
different from pain experienced prior to the procedure
(eg, preopeative angina), (C) is not caused by other
factors (eg, cancer recurrence and chronic infection),
(D) is present for at least 2–3 months and (E) that interferes significantly with health-related quality of life.34–40
If participants answer in the affirmative to each of these
questions, it will be indicated that ‘Yes’ they have developed
CPSP; otherwise, it will be indicated that ‘No’ they have
not. Among those deemed to have developed CPSP (ie,
‘yes’) pain intensity, and its related interference with usual
daily activities, will be measured via the Brief Pain Inventory-Short Form (BPI-SF).103–107 The BPI-SF includes four
11-point NRSs of pain intensity, which measure ‘average’,
‘least’ and ‘worst’ pain intensity in the past 24 hours, respectively, as well as pain intensity ‘now’ (0=no pain, 10=pain
as bad as you can imagine). As is common to studies of
CPSP28 29 62 67 108–113 (including cardiac surgery), participants
will be asked for their ‘worst’ pain intensity rating both on
rest and movement in the past 24 hours. The BPI-SF interference subscale103–107 will also be used, which measures the
degree to which pain interferes with general activity, mood,
walking, work, relations with others, sleep and enjoyment of
life (NRS for each item; 0=does not interfere, 10=completely
interferes). A total interference score is taken by calculating the sum of these seven items. The BPI-SF has strong
psychometric properties with well-established reliability and
validity across divergent surgical groups,29 103–117 including
those reporting acute and chronic pain following cardiac
surgery.28 29 62 67 112 113 The BPI-SF also contains supplemental items,103–106 for optional use (pain treatment and
body diagram). Of these, only the body diagram will be
used for descriptive purposes.
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Functional status
Functional status will be measured with the SF-12v2), an
established reliable and validated health status measure.118
It consists of 12 items taken from the Short Form 36
(SF-36), which is a widely accepted instrument that was
developed from the Medical Outcomes Study.119–121 The
SF-12v2 was developed to reduce respondent burden. It
can be administered by telephone interview and consists
of two scales that measure physical and mental health
status. The SF-12v2 comprises eight domains, measured
via eight subscales: (1) physical functioning; (2) role
limitations due to physical problems; (3) role limitations
due to emotional problems; (4) bodily pain; (5) general
health; (6) vitality; (7) social functioning; and (8) mental
health. Results may be expressed as physical component
summary (PCS) and mental component summary scores.
These scores range from 0 (worst) to 100 (best).118
Cost of illness
The Ambulatory and Home Care Record (AHCR)122–132
will be used to measure patient-level cost of illness from
a societal perspective. This approach gives equal consideration to health system costs and costs borne by patients
and unpaid caregivers, such as family members and
friends. Items in the AHCR can be categorised as publicly
financed care (ie, resources paid for by the public sector)
or privately financed care (ie, all out-of-pocket payments,
third party insurance payments and time costs incurred
by caregiver). Face validity of the AHCR has been assessed
by several healthcare providers, health economists and
administrators who work in the field of ambulatory and
home-based care.122 125 Reliability of the AHCR has been
assessed via the level of agreement between self-reports of
cost by cystic fibrosis care recipients and administrative
data.125 Moderate to almost perfect agreement was found
between study participants’ responses on the AHCR and
administrative data (kappa=0.41–1.00).125 The AHCR
has since been used to evaluate various conditions,124–132
including chronic cardiology patients who were interviewed over the phone131 132 Additionally, the AHCR has
been used to assess costs for an array of patients, including
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Independent variables
Pain-related beliefs
Pain-related beliefs will be examined at baseline using
the PBQ76 77 version II (PBQ-II)74 76–79 133 The PBQ-II134
includes 27 items divided into four subscales: erroneous
beliefs regarding secondary effects of medication (12
items) and their harmful effects (six items), fatalism about
the control of pain (three items) and attitudes regarding
reporting pain to health professionals (six items). Each
item is rated on a 0–5 scale (0: totally disagree; 5: totally
agree). A total score and scores for each subscale can be
calculated by taking the sum of the items. The PBQ-II has
established validity, internal consistency and sensitivity to
change113 135 136 and has recently been adapted and validated for use with cardiac surgical patients.113
Gender-based pain expectations
Gender-based pain expectations will be measured at baseline using the GREP. The GREP87 measures stereotypic
attributions regarding three constructs: pain endurance,
pain sensitivity and willingness to report of pain. Each
construct includes four 100 mm visual analogue scales
regarding how women and men perceive themselves and
the opposite sex, relative to: (A) their own sex and (B) the
opposite sex with respect to how much pain can males/
females endure, how sensitive to pain males/females are
and how willing males/females are to report pain; respondents indicate their views on a 100 mm line anchored by 0
(far less) and 100 (far more). An average score is derived
for each construct; greater scores indicate more stereotypical views. The GREP has now been used in multiple
pain investigations.87 89 91–93 137 138 Test–retest reliability
is acceptable across items87 (0.53 to 0.93), and internal
consistency reliability testing has demonstrated high
correlations (−0.71 to −0.81) between individual items
which assess opposite perceived gender roles (eg, typical
masculine vs feminine orientation to pain endurance).87
Covariates
We will control for the following demographic, clinical
and surgical covariates: sex, age, BMI, diabetes mellitus,
peripheral arterial disease, preoperative chronic pain
and angina (Canadian Cardiovascular Society class),
non-skeletonised internal throacic artery harvest, re-sternotomy and operating time. Additional covariates include
baseline functional status, anxiety and acute post-op pain.
Functional status
We will control for baseline functional status using the
SF-12v2 PCS score.118
Baseline anxiety
We will control for anxiety at baseline using the Spielberger State-Trait Anxiety Inventory (STAI), a widely used,
McGillion MH, et al. BMJ Open 2019;9:e022995. doi:10.1136/bmjopen-2018-022995

well-validated anxiety measure.139 140 The STAI has 40
items that comprise two domains: the State (STAI-S) and
Trait (STAI-T) score, both ranging from 20 to 80, with
higher scores representing higher levels of anxiety. The
STAI-S measures the transitional emotional status evoked
by a stressful situation, such as surgery. The STAI-T score
reflects enduring individual differences in the likelihood
of anxiety.141 The STAI has been found reliable and valid
among patients undergoing cardiac surgery (Cronbach’s
alpha=0.94)142 and is commonly applied in studies capturing
preoperative anxiety among cardiac surgery patients.143 144
Acute post-op pain
Pain on post-op days 3 and 30 will be measured with the
BPI. Cumulative 24 hours analgesic on post-op day 3,
as an indication of analgesic dosing in hospital during
recovery, will be determined via chart audit using a tool
we have used in previous cardiac studies.28 62 67 Opioid
dosage will be converted into parenteral morphine equivalents per day using standard dosage tables.28 62 67
Sample size
The primary analysis for this study is the association of
pain-related beliefs and gender-based pain expectations
with CPSP at 6 months and 12 months while adjusting for
a number of prespecified covariates. Therefore, sample
size was calculated based on the methods used by Hsieh
and colleagues145 for multivariable logistic regression. In
this validated method, the sample size for a simple logistic
regression modelling a single independent variable X1 on
the outcome is inflated by a variance inflation factor equal
to 1 / (1-ρ2×2…xp), where ρ2×2…xp is equal to the proportion of the variance of X1 explained by the regression
relationship with X2…Xp.145 Additionally, sample size was
inflated to account for the clustered nature of the data (ie,
6-month and 12-month measurements) by incorporating
an additional design effect equivalent to 1+ (m−1)*ρICC,
where m is the number of measurements per cluster (ie,
two time points) and ρICC represents the correlation
of responses within clusters. A conservative scenario was
assumed in which the correlation between the two follow-up
measurements could be as high as 0.60, and the variance of
the independent variables explained by covariates (ie, R2)
was 0.16, resulting in a requirement of 1250 participants to
detect a significant change in the odds of post-op pain of
5% (ie, OR of 1.05). This calculation allows the prevalence
of CPSP to be as low as 10% (as found in some previous
studies). Should the prevalence of CPSP be higher, the
correlation between measurements be smaller, or the variance explained in the independent variables be smaller,
1250 participants will provide >80% power.145
Data analyses
Categorical data (eg, presence or absence of CPSP at 6
months and 1 year) will be summarised with frequencies and proportions. Continuous data (eg, functional
disability scores) will be evaluated for normality using
Shapiro-Wilk tests of normality and summarised using
7
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the elderly, middle-aged adults and children.122–132 The
AHCR has been used in telephone and face-to-face interviews as well as in mailed form; it has been translated into
several languages.122–132
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Ethics and dissemination
Both integrated and end-of-grant dissemination strategies will be implemented. Study progress and results
will be disseminated on CardiacPain.Net,154 a web-based
pain resource centre (http://cardiacpain.onlinecjc.ca/)
linked to Elsevier’s global online readership, featuring
active knowledge ‘push’ mechanisms including e-banner
advertising and opt-in email blasts. Final results will be
8

presented at international conferences and published in
scientific journals.
Implications
CPSP is an important socioeconomic problem with
well-documented deleterious consequences on functional status for cardiac patients. We aim to investigate
putative psychological risk factors that could be targeted
for preventative intervention. We will also examine the
economic consequences of CPSP comprehensively,
including the impact on QALYs, with no additional data
collection required. This study may contribute towards
reducing the risk and impact of CPSP after cardiac
surgery.
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measures of central tendency and dispersion (eg, means
and SD for normally distributed factors and medians and
IQRs for non-normally distributed data). Generalised
estimating equations (GEEs) will be used to model the
primary analysis: the association between pain-related
beliefs and gender-based pain expectations with the development of CPSP at 6 months and 1 year while adjusting
for prespecified covariates. GEE models account for
the lack of independence in outcome measurements
introduced by multiple measurements.146 We will enter
all prespecified variables in the model and retain them
throughout the analysis. For each model, the inclusion
of an interaction term between the two independent variables of interest (pain belief scale and gender- based pain
expectations) will be guided by 95% CIs and likelihood
ratio significance tests. Model diagnostics will consist of
influential observation examination and Breslow-Day
tests for goodness of fit.147 148 We will also assess for multicollinearity in our model via assessment of condition
indices.147 148
QALYs100 101 will be estimated by converting SF-12v2
data collected in the study to utility score using a validated algorithm.149 After estimating QALYs, we will
analyse it as a dependent variable using regression to estimate the difference in expected QALYs between the two
groups (ie, those with CPSP vs those without). In addition, after calculating total cost from the AHCR, we will
analyse it as a dependent variable using regression to estimate the difference in expected healthcare cost between
the two groups (ie, patients with CPSP vs those without).
Employing regression will allow for the adjustment of
potential confounders. With a variety of different types
of regression (ie, ordinary least squares and generalised
linear models), we will explore the impact of various
modelling assumptions. In addition, we will compare
parametric and non-parametric CIs using bootstrapping.
In theory, an ordinary least squares model produces
unbiased estimates even if the data are skewed; however,
different estimation methods (eg, generalised linear
models) and different uncertainty methods (eg, non-parametric bootstrapping) will facilitate careful investigation of the impact that various assumptions have on our
conclusions.150–153 The regression models will provide
estimates of differences in QALYs and costs for participants who develop CPSP versus those who do not develop
CPSP, which will allow us to calculate incremental cost for
one QALY gained. A cost-effectiveness acceptability curve
and 95% CI will be used to characterise the uncertainty
of our findings.153
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